The numbers of individuals with oral manifestations of systemic disease is ever rising
The oral symptoms can sometimes be the first, only and/or most distressing feature of systemic disease
Oral Health care providers will often be the first clinicians to recognise oral features of systemic disease
While the majority of disorders of the mouth are centred upon the direct action of plaque, the oral tissues can be subject to change or damage as a consequence of disease that predominantly affects other body systems. Such oral manifestations of systemic disease can be highly variable in both frequency and presentation. As lifespan increases and medical care becomes ever more complex and effective it is likely that the numbers of individuals with oral manifestations of systemic disease will continue to rise. The present article provides a succinct review of oral manifestations of systemic disease. In view of this article being part of a wider BDJ themed issue on the subject of oral medicine, this review focuses upon oral mucosal and salivary gland disorders that may arise as a consequence of systemic disease.
Subscribe to Journal
Get full journal access for 1 year
only $20.79 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Compilato D, Corsello G, Campisi G . An unusual traumatic ulceration of the tongue. J Paediatr Child Health 2012; 48: 1104–1105.
Gilvetti C, Porter S R, Fedele S . Traumatic chemical oral ulceration: a case report and review of the literature. Br Dent J 2010; 208: 297–300.
Radoï L, Luce D . A review of risk factors for oral cavity cancer: the importance of a standardized case definition. Community Dent Oral Epidemiol 2013; 41: 97–109.
Ray J G, Swain N, Ghosh R, Richa, Pattanayak Mohanty S. Dyskeratosis congenita with malignant transformation. BMJ Case Rep 2011; 2011: 10.1136/bcr.03.2010.2848.
Wong W M, Parvathaneni U, Jewell P D et al. Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: a case report and review of the literature. Head Neck 2013; 35: E292–298.
Fitzpatrick S G, Hirsch S A, Gordon S C . The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 2014; 145: 45–56.
Kuo C F, Luo S F, Yu K H et al. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 2012; 41: 44–49.
Michalek A M, Mahoney M C, McLaughlin C C, Murphy D, Metzger B B . Historical and contemporary correlates of syphilis and cancer. Int J Epidemiol 1994; 23: 381–385.
Triantafillidou K, Dimitrakopoulos J, Iordanidis F, Gkagkalis A . Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature. J Oral Maxillofac Surg 2012; 70: 2776–2785
Porter S R, Diz Dios P, Kumar N, Stock C, Barrett A W, Scully C . Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 730–734.
Castillo J J, Bibas M, Miranda R N . The biology and treatment of plasmablastic lymphoma. Blood 2015; 125: 2323–2330.
Al-Hakeem D A, Fedele S, Carlos R, Porter S . Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 2007; 43: 4–14.
Patton L L . Oral lesions associated with human immunodeficiency virus disease. Dent Clin North Am 2013; 57: 673–698.
Rao R S, Patil S, Sanketh D, Amrutha N . Metastatic tumors of the oral cavity. J Contemp Dent Pract 2014; 15: 263–271.
Ilyas S E, Chen F F, Hodgson T A, Speight P M, Lacey C J, Porter S R . Labial tuberculosis: a unique cause of lip swelling complicating HIV infection. HIV Med 2002; 3: 283–286.
Aoun N, El-Hajj G, El Toum S . Oral ulcer: an uncommon site in primary tuberculosis. Aust Dent J 2015; 60: 119–122.
Iatta R, Napoli C, Borghi E, Montagna M T . Rare mycoses of the oral cavity: a literature epidemiologic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108: 647–655.
Porter S R, Scully C, Standen G R . Autoimmune neutropenia manifesting as recurrent oral ulceration. Oral Surg Oral Med Oral Pathol 1994; 78: 178–180.
Jurge S, Kuffer R, Scully C, Porter S R . Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Dis 2006; 12: 1–21.
Al-Otaibi L M, Porter S R, Poate T W . Behçet's disease: a review. J Dent Res 2005; 84: 209–222.
Stojanov S, Lapidus S, Chitkara P et al. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci USA 2011; 108: 7148–7153.
Scully C, Hodgson T, Lachmann H . Auto-inflammatory syndromes and oral health. Oral Dis 2008; 14: 690–699.
Scully C, Porter S . Orofacial disease: update for the dental clinical team: 2. Ulcers, erosions and other causes of sore mouth. Part II. Dent Update 1999; 26: 31–39.
Ryan K, Hegarty A M, Hodgson T . Aetiology, diagnosis and treatment of oral lichen planus. Br J Hosp Med (Lond) 2014; 75: 492–496.
Bidarra M, Buchanan J A, Scully C, Moles D R, Porter S R . Oral lichen planus: a condition with more persistence and extra-oral involvement than suspected? J Oral Pathol Med 2008; 37: 582–586.
Lourenço S V, de Carvalho F R, Boggio P et al. Lupus erythematosus: clinical and histopathological study of oral manifestations and immunohistochemical profile of the inflammatory infiltrate. J Cutan Pathol 2007; 34: 558–564.
Nico M M, Vilela M A, Rivitti E A, Lourenço S V . Oral lesions in lupus erythematosus: correlation with cutaneous lesions. Eur J Dermatol 2008; 18: 376–381.
Xu H H, Werth V P, Parisi E, Sollecito T P . Mucous membrane pemphigoid. Dent Clin North Am 2013; 57: 611–630.
Leao J C, Ingafou M, Khan A, Scully C, Porter S . Desquamative gingivitis: retrospective analysis of disease associations of a large cohort. Oral Dis 2008; 14: 556–560.
Chan L S . Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid). Clin Dermatol 2012; 30: 34–37.
Kasperkiewicz M, Zillikens D, Schmidt E . Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 2012; 45: 55–70.
Lähteenoja H, Irjala K, Viander M, Vainio E, Toivanen A, Syrjänen S . Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol 1998; 134: 756–758.
Said S, Golitz L . Vesiculobullous eruptions of the oral cavity. Otolaryngol Clin North Am 2011; 44: 133–160, vi.
Dan H, Lu R, Li W, Chen Q, Zeng X . Linear IgA disease limited to the oral mucosa. J Am Acad Dermatol 2011; 65: 677–679.
Eguia del Valle A, Aguirre Urízar J M, Martínez Sahuquillo A . Oral manifestations caused by the linear IgA disease. Med Oral 2004; 9: 39–44.
Sticherling M, Erfurt-Berge C . Autoimmune blistering diseases of the skin. Autoimmun Rev 2012; 11: 226–230.
Santoro F A, Stoopler E T, Werth V P . Pemphigus. Dent Clin North Am 2013; 57: 597–610.
Niimi Y, Ohyama B, Di Zenzo G, Calabresi V, Hashimoto T, Kawana S . Paraneoplastic pemphigus presenting as mild cutaneous features of pemphigus foliaceus and lichenoid stomatitis with antidesmoglein 1 antibodies. Dermatol Res Pract 2010; 2010: 10.1155/2010/931340.
Cozzani E, Rosa G M, Drosera M, Intra C, Barsotti A, Parodi A . ACE inhibitors can induce circulating antibodies directed to antigens of the superficial epidermal cells. Arch Dermatol Res 2011; 303: 327–332.
Al-Johani K A, Fedele S, Porter S R . Erythema multiforme and related disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 642–654.
Muzyka B C, Epifanio R N . Update on oral fungal infections. Dent Clin North Am 2013; 57: 561–581.
Stoopler E T, Sollecito T P . Oral mucosal diseases: evaluation and management. Med Clin North Am. 2014; 98: 1323–1352.
Lanternier F, Cypowyj S, Picard C, Bustamante J, Lortholary O, Casanova J L, Puel A . Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr 2013; 25: 736–747.
Kisand K, Peterson P . Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis. Curr Opin Pediatr 2013; 25: 715–721.
Lindh E, Brännström J, Jones P et al. Autoimmunity and cystatin SA1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome type 1. J Autoimmun 2013; 42: 1–6.
Capalbo D, Improda N, Esposito A et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy from the pediatric perspective. J Endocrinol Invest 2013; 36: 903–912.
Porter S R, Scully C . Candidiasis endocrinopathy syndrome. Oral Surg Oral Med Oral Pathol 1986; 61: 573–578.
Kelesidis T, Yang O . Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. Clin Immunol 2010; 135: 347–363.
Shephard M K, Schifter M, Palme C E . Multiple oral squamous cell carcinomas associated with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114: e36–e42.
Porter S R, Mercadante, V, Fedele S . Non-neoplastic salivary gland disease. In Scott-Brown's Otorhinolaryngology: Head & Neck Surgery, eighth edition. Hodder Arnold: London (in press).
Jeffers L K, Madden V, Webster-Cyriaque J . BK virus has tropism for human salivary gland cells in vitro: Implications for transmission. Virology 2009; 394: 183–193.
Burger-Calderon R, Madden V, Hallett R A, Gingerich A D, Nickeleit V, Webster-Cyriaque J . Replication of oral BK virus in human salivary gland cells. J Virology 2014; 88: 559–573.
Mahajan V S, Mattoo H, Deshpande V, Pillai S S, Stone J H . IgG4-related disease. Ann Rev Pathol 2014; 9: 315–347.
Deshpande V, Zen Y, Chan J K C et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25: 1181–1192.
Mandel L, Khelemsky R . Asymptomatic bilateral facial swelling. J Am Dent Assoc 2012; 143: 1205–1208.
Capoccia L, Sbarigia E, Speziale F . Monolateral sialadenitis following iodinated contrast media administration for carotid artery stenting. Vascular 2010; 18: 34–36.
Chau A M T, Suan D . Iodide mumps. Clinical Imaging 2013; 37: 367–368.
Shacham Y, Havakuk O, Roth A . A rare case of acute contrast-induced sialadenitis after percutaneous coronary intervention. Israel Med Assoc J 2013; 15: 652–653.
Brooks K G, Thompson DF . A review and assessment of drug-induced parotitis. Ann Pharmacother 2012; 46: 1688–1699.
Jensen S B, Pedersen A M L, Vissink A et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: Prevalence, severity and impact on quality of life. Support Care Cancer 2010; 18: 1039–1060.
Konings A W T, Coppes R P, Vissink A . On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 2005; 62: 1187–1194.
Reksten T R, Jonsson M V . Sjögren's Syndrome: An update on epidemiology and current insights on pathophysiology. Oral Maxillofac Surg Clin North Am 2014; 26: 1–12.
Voulgarelis M, Ziakas P D, Papageorgiou A, Baimpa E, Tzioufas A G, Moutsopoulos H M . Prognosis and outcome of non-hodgkin lymphoma in primary Sjögren syndrome. Medicine 2012; 91: 1–9.
Routsias J G, Goules J D, Charalampakis G, Tzima S, Papageorgiou A, Voulgarelis M . Malignant lymphoma in primary Sjögren's syndrome: An update on the pathogenesis and treatment. Semin Arthritis Rheum 2013; 43: 178–186.
About this article
Cite this article
Porter, S., Mercadante, V. & Fedele, S. Oral manifestations of systemic disease. Br Dent J 223, 683–691 (2017). https://doi.org/10.1038/sj.bdj.2017.884
Prevalence of and related risk factors in oral mucosa diseases among residents in the Baoshan District of Shanghai, China
Special Care in Dentistry (2020)
How to deal with coronavirus disease 2019: A comprehensive narrative review about oral involvement of the disease
Clinical and Experimental Dental Research (2020)
BMJ Case Reports (2020)
Characterization of oral candidiasis and the Candida species profile in patients with oral mucosal diseases
Microbial Pathogenesis (2019)